Other formats:
BibTeX
LaTeX
RIS
@proceedings{2220969,
author = {Straka, Matej and Rohan, Tomáš and Matkulčík, Peter and Hustý, Jakub and Andrašina, Tomáš},
booktitle = {CIRSE 2022},
doi = {http://dx.doi.org/10.1007/s00270-022-03246-4},
keywords = {hepatocellular carcinoma; HCC; transarterial chemoembolisation; TACE; complications; degradable particles; DSM TACE},
language = {eng},
title = {Assessment of rate of major complications in transarterial chemoembolization using degradable starch microspheres versus permanent embolization particles in patients with hepatocellular carcinoma},
url = {https://programme.cirse2022.cirse.org/cirse2022/crs/assessment-of-rate-of-major-complications-in-transarterial-chemoembolization-using-degradable-starch-microspheres-versus-permanent-embolization-particles-in-patients-with-hepatocellular-carcinoma},
year = {2022}
}
TY - CONF
ID - 2220969
AU - Straka, Matej - Rohan, Tomáš - Matkulčík, Peter - Hustý, Jakub - Andrašina, Tomáš
PY - 2022
TI - Assessment of rate of major complications in transarterial chemoembolization using degradable starch microspheres versus permanent embolization particles in patients with hepatocellular carcinoma
KW - hepatocellular carcinoma
KW - HCC
KW - transarterial chemoembolisation
KW - TACE
KW - complications
KW - degradable particles
KW - DSM TACE
UR - https://programme.cirse2022.cirse.org/cirse2022/crs/assessment-of-rate-of-major-complications-in-transarterial-chemoembolization-using-degradable-starch-microspheres-versus-permanent-embolization-particles-in-patients-with-hepatocellular-carcinoma
N2 - Purpose: To analyze whether transarterial chemoembolization (TACE) using degradable starch microspheres (DSM-TACE) or permanent embolizing particles (DEB-TACE) cause significant difference in rate of major periprocedural complications in patients with hepatocellular carcinoma (HCC). Materials and methods: Prospective assessment of major periprocedural complications in 226 TACE procedures between 2018-2021 in 57 consecutive patients with HCC was performed. Study group consists of 110 DSM-TACE procedures, the control group consists of 116 procedures using permanent embolizing particles. Major complications were followed up to 30 days after each TACE (contrast-enhanced CT, laboratory parameters, clinical status). Our data underwent statical analyses (chi-squared test). Results: There was significant difference in complication per procedure in the study and the control group (3% vs 14% p=0,006). Complications after TACE included severe postembolization syndrome (n=11), liver ischemia caused by reflux of permanent particles (n=4), liver abscess (n=2), cholangitis (n=2), allergic reaction (n=1). Conclusion: Patients with HCC treated with TACE using permanent embolization particles have significantly higher frequency of major postprocedural complication compared to patients with HCC treated with TACE using degradable particles.
ER -
STRAKA, Matej, Tomáš ROHAN, Peter MATKULČÍK, Jakub HUSTÝ and Tomáš ANDRAŠINA. Assessment of rate of major complications in transarterial chemoembolization using degradable starch microspheres versus permanent embolization particles in patients with hepatocellular carcinoma. In \textit{CIRSE 2022}. 2022. Available from: https://dx.doi.org/10.1007/s00270-022-03246-4.
|
